+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Okt3 treatment of acute renal allograft rejection rjxn resistant to high dose methylprednisolone mp and or anti thymocyte globulin atg



Okt3 treatment of acute renal allograft rejection rjxn resistant to high dose methylprednisolone mp and or anti thymocyte globulin atg



Kidney International 31(1): 456




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028825745

Download citation: RISBibTeXText


Related references

Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants. Pediatric Nephrology. 7(3): 259-262, 1993

Randomized trial of anti thymocyte globulin atg vs. high dose steroids for acute rejection rjxn of renal transplants long term follow up. Kidney International 31(1): 454, 1987

OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A. Transplantation Proceedings 20(5 Suppl 6): 90-95, 1988

Reversal of methylprednisolone resistant acute allograft rejection with anti thymocyte globulin. Kidney International 26(4): 632, 1984

The high failure rate of OKT3 in the treatment of acute renal allograft rejection resistant to steroids with or without antithymocyte globulin. Transplantation 52(4): 746-749, 1991

Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A. Transplantation Proceedings 21(1 Pt 2): 1736-1737, 1989

Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Transplantation Proceedings 40(1): 137-139, 2008

Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin. Transplantation 45(1): 65-67, 1988

Serum sickness following rabbit anti-thymocyte globulin for acute vascular renal allograft rejection. Clinical Kidney Journal 5(4): 334-335, 2012

Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection. Transplantation 62(1): 38-42, 1996

OKT3 for the treatment of steroid-resistant acute renal allograft rejection. Nephron 77(3): 298-303, 1997

Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection. Transplantation 47(2): 272-277, 1989

First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization. Transplantation Proceedings 22(1): 221-222, 1990

Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children. British Medical Journal 285(6337): 258-260, 1982

Low-dose vs high-dose methylprednisolone therapy for the treatment of renal allograft rejection. Nephrology Dialysis Transplantation 5(4): 320, 1990